David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG , Walsh GL, Vaporciyan AA, Thall P, Mehran RJ
Consequently, therapeutic strategies have shifted toward indirect, receptor-mediated modulation
Verified Customers Reviews
433 In the BrighTNess study, which evaluated veliparib in neoadjuvant settings in early-stage TNBC patients, showed that the addition of veliparib neither improved the rate of pCR vs standard chemotherapy nor the event-free survival
For dramatic skin whitening claims often seen in marketing, evidence is weaker and results are typically modest rather than dramatic
Moxibustion can downregulate p53 and ROS, upregulate SLC7A11, GPX4 expression, and reduce ferroptosis